logo

UTHR

United Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

UTHR fundamentals

United Therapeutics (UTHR) released its earnings on Oct 29, 2025: revenue was 799.50M (YoY +6.76%), missed estimates; EPS was 7.16 (YoY +12.05%), beat estimates.
Revenue / YoY
799.50M
+6.76%
EPS / YoY
7.16
+12.05%
Report date
Oct 29, 2025
UTHR Earnings Call Summary for Q3,2025
  • Record Q3 2025 Results: $800M revenue (+7% YoY), driven by Tyvaso DPI and Orenitram growth.
  • $4B 2027 Run Rate Target: Ambitious goal reflecting confidence in IPF and PH-ILD expansion.
  • Innovative Product Launches: 80-microgram Tyvaso DPI cartridge and RemunityPRO pump enhance patient convenience.
  • Ralinepag Partnership Potential: Long patent life (2040) and synergistic effects position for strategic deals.
  • TETON 2 IPF Impact: Unblinded data shows unprecedented benefits, with physician interest in dual PH/IPF treatment.
EPS
Revenue

Revenue & Expenses

UTHR has released its 2025 Q3 earnings report, with revenue of 799.50M, reflecting a YoY change of 6.76%, and net profit of 338.70M, showing a YoY change of 9.58%. The Sankey diagram below clearly presents UTHR's revenue sources and cost distribution.

Key Indicators

United Therapeutics (UTHR) key financial stats and ratios, covering profitability, financial health, and leverage.
United Therapeutics (UTHR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
United Therapeutics (UTHR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
United Therapeutics (UTHR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does United Therapeutics (UTHR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track United Therapeutics (UTHR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield